JP drafts for public comments, September 1 - November 30, 2020
New monographs
- Temozolomide[214KB] (001-2009eng.pdf)
- Temozolomide Capsules[210KB] (002-2009eng.pdf)
- Temozolomide for Injection[208KB] (003-2009eng.pdf)
Ultraviolet-visible reference spectra
- Temozolomide[41.8KB] (004-2009eng.pdf)
Infrared reference spectra
- Temozolomide[122KB](005-2009eng.pdf)
To send the comment on these drafts, the guidance is as follows:
- Download the form for comments in Word format[67.0KB]
- Fill in the form
- Prepare and attach the supportive data that scientifically validate the comment when appropriate
- Send it to the email address: JPdraft2009eng[at]pmda.go.jp
Note:
For the purpose of security, this email address is partly incorrect. Please replace [at] with @ when sending an email.
Related Information
Note:
The information submitted with the comments may be released to the public whenever necessary (except the individual name, organization, address, telephone & fax numbers and e-mail address or the attached supportive data).
Your comments will be considered for the preparation of JP final drafts, but no individual response will be made to each comment.